Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-24T19:54:49.018Z Has data issue: false hasContentIssue false
  • English
  • Français

Political Versus Epidemiological Correctness

Published online by Cambridge University Press:  02 January 2015

Barry M. Farr
Barry M. Farr*
Affiliation:
University of Virginia Health System, Charlottesville, Virginia
*
Department of Medicine, PO Box 800473, University of Virginia Health System, Charlottesville, VA 22908 (bmf@virginia.edu)
Get access Rights & Permissions [Opens in a new window]

Extract

In the March issue of the journal, the Joint SHEA and APIC Task Force indicates that the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC) support the use of active detection and isolation (ADI) for controlling nosocomial infections due to methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) “in appropriate circumstances, as recommended in previously published guidelines”1(p250) (those published by SHEA and the Healthcare Infection Control Practices Advisory Committee [HICPAC]), but that SHEA and APIC oppose the use of legislation for mandating any infection control approach, including this one as tried in 2006 in Illinois and Maryland.

Both supporters and opponents of controlling MRSA and VRE with ADI probably will agree that legislation is not the optimal way to control nosocomial infections in general, but this position statement undoubtedly will please the latter more than it does the former because the SHEA/APIC Task Force argues that ADI is not ready for routine use throughout all healthcare facilities, directly opposing the position of the original SHEA guideline. As an author of that SHEA guideline, I would like to comment. First, the new position seems politically correct (since most infection control professionals have not yet bothered using ADI to control MRSA and VRE), but many of the planks of the SHEA/APIC Task Force position statement are misleading.

Type
Readers' Forum
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 5 , May 2007 , pp. 589 - 593
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Weber, SG, Huang, SS, Oriola, S, et al. Legislative mandates for active surveillance cultures for MRSA and VRE: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol 2007;28:249–260.CrossRefGoogle ScholarPubMed
2. Muto, CA, Jernigan, JA, Ostrowsky, BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus . Infect Control Hosp Epidemiol 2003;24: 362–386. Available at: http://www.shea-onHne.org/Assets/files/position_papers/SHEA_MRSA_VRE.pdf. Accessed March 21, 2007.Google Scholar
3. Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L, the Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed November 13, 2006.Google Scholar
4. Illinois General Assembly. Bill Status of SB2771, 94th General Assembly. Available at: http://www.ilga.gov/legislation/BillStatus.aspTGA = 948c DocTypelD = SB&DocNum = 2771 &G AID = 8&SessionID = 50&LegID = 23855. Accessed January 10, 2007.Google Scholar
5. Illinois General Assembly. Bill Status of SB3087, 94th General Assembly. Available at: http://www.ilga.gov/legislation/billstatus.asp?DocNum = 30878tGAID = 8&GA = 94&DocTypeID = SB8cLegID = 242188cSessionID = 50. Accessed January 10, 2007.Google Scholar
6. Peterson, L. Lessons to be shared in successful reductions of infections. Illinois Quality Leadership Conference—Focusing on Reducing and Eliminating Infections. Naperville, IL: Hospital Association and Metropolitan Chicago Healthcare Council; May 24, 2006.Google Scholar
7. Maryland General Assembly. Hospitab and Nursing Fadlities—Healthcare-Associated Infections Prevention and Control Program. Available at: http://mlis.state.md.us/2006rs/bills/sb/sb0535f.pdf. Accessed March 21, 2007.Google Scholar
8. Farr, BM. What to think if results of the NIH randomized trial of MRSA and VRE control is negative (and other advice to young epidemiologists): a review and an au revoir. Infect Control Hosp Epidemiol 2006;27:1096–1106.Google Scholar
9. Farr, BM. Doing the right thing (and figuring out what that is). Infect Control Hosp Epidemiol 2006;27:999–1003.Google Scholar
10. Jernigan, JA, Titus, MG, Groschel, DH, Getchell-White, S, Farr, BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus . Am J Epidemiol 1996;143:496–504.CrossRefGoogle ScholarPubMed
11. Thompson, RL, Cabezudo, I, Wenzel, RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus . Ann Int Med 1982;97:309–317.CrossRefGoogle ScholarPubMed
12. Pan, A, Carnevale, G, Catenazzi, P, et al. Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA “search and isolate” strategy in a hospital in Italy with hyper-endemic MRSA. Infect Control Hosp Epidemiol 2005;26:127–133.Google Scholar
13. Ostrowsky, BE, Trick, WE, Sohn, AH, et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001;344:1427–1433.CrossRefGoogle ScholarPubMed
14. Kotilainen, P, Routamaa, M, Peltonen, R, et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 2001;161:859–863.Google Scholar
15. Harberg, D. Society for Healthcare Epidemiology of America guideline approach works to control a methicillin-resistant Staphylococcus aureus outbreak. Infect Control Hosp Epidemiol 2005;26:115–116.Google Scholar
16. Silverblatt, FJ, Tibert, C, Mikolich, D, et al. Preventing the spread of vancomycin-resistant enterococci in a long-term care facility. J Am Geriatr Soc 2000;48:1211–1215.Google Scholar
17. Dailey, L, Coombs, GW, O'Brien, FG, et al. Methicillin-resistant Staphylococcus aureus, Western Australia. Emerg Infect Dis 2005;11:1584–1590.CrossRefGoogle ScholarPubMed
18. Verhoef, J, Beaujean, D, Blok, H, et al. A Dutch approach to methicillin-resistant Staphylococcus aureus . Eur J Clin Microbiol Infect Dis 1999;18:461–466.CrossRefGoogle ScholarPubMed
19. Tiemersma, EW, Monnet, DL, Bruinsma, N, Skov, R, Monen, JC, Grandmann, H. Staphylococcus aureus bacteremia, Europe. Emerg Infect Dis 2005;11:1798–1799.Google Scholar
20. Tiemersma, EW, Bronzwaer, SL, Lyytikainen, O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004;10:1627–1634.CrossRefGoogle ScholarPubMed
21. Salgado, C, Farr, B. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiology cultures? Infect Control Hosp Epidemiol 2006;27:116–121.Google Scholar
22. Calfee, DP, Giannetta, ET, Durbin, LJ, Germanson, TP, Farr, BM. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis 2003;37:326–332.Google Scholar
23. Strausbaugh, LJ, Siegel, JD, Weinstein, RA. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of two guidelines. Clin Infect Dis 2006;42:828–835.CrossRefGoogle Scholar
24. Boyce, JM, Pittet, D, Healthcare Infection Control Practices Advisory Committee. Society for Healthcare Epidemiology of America. Association for Professionals in Infection Control. Infectious Diseases Society of America. Hand Hygiene Task Force. Guideline for Hand Hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002;23(12 suppl):S3–40.Google Scholar
25. Webster, J, Faoagali, JL, Cartwright, D. Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 1994;30:59–64.CrossRefGoogle ScholarPubMed
26. Vriens, MR, Fluit, AC, Troelstra, A, Verhoef, J, van der Werken, C. Is methicillin-resistant Staphylococcus aureus more contagious than meth-icillin-susceptible S. aureus in a surgical intensive care unit [erratum appears in Infect Control Hosp Epidemiol 2002;23:579]. Infect Control Hosp Epidemiol 2002;23:491–494.Google Scholar
27. Esveld, MI, de Boer, AS, Notenboom, AJ, van Pelt, W, van Leeuwen, WJ. Secondary infection with methicillin resistant Staphylococcus aureus in Dutch hospitals (July 1997-June 1996). Nederlands Tijdschrift voor Ge-neeskunde 1999;143:205–208.Google Scholar
28. Blank, M, Haas, L, Donahoe, M, Kramer, P, Muto, C. Sustained effect in reducing methicillin-resistant Staphylococcus aureus (MRSA) hospital-acquired infections (HAIs) using active MRSA surveillance cultures (MSC)—three year follow-up. In: Program and abstracts of the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Los Angeles). 2005:64. Abstract 22.Google Scholar
29. Huang, SS, Yokoe, DS, Hinrichsen, VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006;43:971–978.Google Scholar
30. Verbrugh, HA. Best practices from The Netherlands. In: Program and abstracts of the 2nd Infection Prevention and Control Conference: Managing MRSA—A Call To Action. Co-convened by the Association for Professionals in Infection Control and Epidemiology and Joint Commission Resources;August 15, 2006; Cambridge, MA.Google Scholar
31. Calfee, DP, Saigado, CD, Giannetta, ET, Farr, BM. Effectiveness of surveillance cultures (SC) and contact precautions (CP) for controlling methicillin-resistant S. aureus (MRSA) and vancomycin- resistant Enterococcus (VRE) in a non-academic community hospital. In: Program and abstracts of the 14th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Philadelphia). 2004:128. Abstract 363.Google Scholar
32. West, TE, Guerry, C, Hiott, M, Morrow, N, Ward, K, Saigado, CD. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 2006;27:233–238.Google Scholar
33. Jernigan, JA, Clemence, MA, Stott, GA, et al. Control of methicillin resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995;16:686–696.Google Scholar
34. Farrington, M, Redpath, C, Trundle, C, Coomber, S, Brown, NM. Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus (MRSA) infection at a teaching hospital. QJM 1998;91:539–548.Google Scholar
35. Smith, DL, Dushoff, J, Perencevich, EN, Harris, AD, Levin, SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA 2004;101:3709–3714.Google Scholar
36. Smith, DL, Levin, SA, Laxminarayan, R. Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci USA 2005;102:3153–3158.Google Scholar
37. da Silva Coimbra, MV, Silva-Carvalho, MC, Wisplinghoff, H, et al. Clonal spread of methicillin-resistant Staphylococcus aureus in a large geographic area of the United States. J Hosp Infect 2003;53:103–110.Google Scholar
38. Vandenbroucke-Grauls, CM, Frenay, HM, van Klingeren, B, Savelkoul, TF, Verhoef, J. Control of epidemic methicillin-resistant Staphylococcus aureus in a Dutch university hospital. Eur J Clin Microbiol Infect Dis 1991;10:6–11.Google Scholar
39. Seeberg, S, Larsson, L, Welinder-Olsson, C, et al. How an outbreak of MRSA in Gothenburg was eliminated: by strict hygienic routines and massive control-culture program. Lakartidningen 2002;99:3198–3204.Google Scholar
40. Kotilainen, P, Routamaa, M, Peltonen, R, et al. Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis 2003;9:169–175.Google Scholar
41. Lucet, JC, Paoletti, X, Lolom, I, et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005;31:1051–1057.Google Scholar
42. Montecalvo, MA, Jarvis, WR, Uman, J, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Int Med 1999;131:269–272.Google Scholar
43. Stelfox, HT, Bates, DW, Redelmeier, DA. Safety of patients isolated for infection control. JAMA 2003;290:1899–1905.Google Scholar
44. Haley, RW, Cushion, NB, Tenover, FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995;171:614–624.Google Scholar
45. Muto, CA, Giannetta, ET, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus . Infect Control Hosp Epidemiol 2002;23:429–435.Google Scholar
46. Karchmer, TB, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus . J Hosp Infect 2002;51:126–132.Google Scholar
47. Vernon, M, Haydem, M, Trick, W, et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit. Arch Intern Med 2006;166:306–312.Google Scholar
48. Beck-Sague, CM, Dooley, SW, Hutton, MD, et al. Outbreak of multidrug-resistant tuberculosis among persons with HIV infection in an urban hospital: transmission to staff and patients and control measures. JAMA 1992;268:1280–1286.Google Scholar
49. Clancy, M, Graepler, A, Wilson, M, Douglas, I, Johnson, J, Price, CS. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 2006;27:1009–1017.CrossRefGoogle ScholarPubMed
50. Urth, T, Juul, G, Skov, R, Schonheyder, HC. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol 2005;26:144–149.Google Scholar
51. Rubin, Z, Edwards, Jr, Horan, TS, Jernigan, JA. Staphylococcal surgical site infection following coronary artery bypass and joint replacement surgery, National Nosocomial Infections Surveillance System, 1994-2003. In: Program and abstracts of the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Los Angeles). 2005. Abstract 42.Google Scholar
52. Muto, CA, Blank, MK, Pokrywka, M, et al. Reduction of methicillin-resistant Staphylococcus aureus (MRSA) hospital acquired infections in a medical ICU: effect of a MRSA control initiative during a concurrent central line associated BSI reduction initiative. In: Program and abstracts of the 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Chicago). 2006:86. Abstract 67.Google Scholar
53. Klevens, R, Edwards, J, Tenover, F, McDonald, L, Horan, T, Gaynes, R. National Nosocomial Infections Surveillance System. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006;42:389–391.Google Scholar
54. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.Google Scholar
55. Strausbaugh, LJ, Jacobson, C, Yost, T. Methicillin-resistant Staphylococcus aureus in a nursing home and affiliated hospital: a 4-year perspective. Infect Control Hosp Epidemiol 1993;14:331–336.Google Scholar
56. Hartstein, AI. Improved understanding and control of nosocomial methicillin-resistant Staphylococcus aureus: are we overdoing it? Infect Control Hosp Epidemiol 1995;16:257–259.Google Scholar
57. Barrett, SP, Mummery, RV, Chattopadhyay, B. Trying to control MRSA causes more problems than it solves. J Hosp Infect 1998;39:85–93.Google Scholar
58. Farr, BM, Weinstein, RA. Controlling VRE and MRSA: standard precautions vs. surveillance cultures and contact precautions. In: Program and abstracts of the 40th Annual Meeting of the Infectious Diseases Society of America (Chicago). 2002:6 (addendum). Abstract S10.Google Scholar